Zafgen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Zafgen and buy or sell other stocks, ETFs, and their options commission-free!About ZFGN
Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders.
CEOJeffrey S. Hatfield, MBA
CEOJeffrey S. Hatfield, MBA
Employees65
Employees65
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2005
Founded2005
Employees65
Employees65
ZFGN Key Statistics
Market cap530.66M
Market cap530.66M
Price-Earnings ratio-1.79
Price-Earnings ratio-1.79
Dividend yield—
Dividend yield—
Average volume1.15M
Average volume1.15M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.37
52 Week high$5.37
52 Week low$1.61
52 Week low$1.61
Stock Snapshot
As of today, Zafgen(ZFGN) shares are valued at $6.20. The company's market cap stands at 530.66M, with a P/E ratio of -1.79.
During the trading day, Zafgen(ZFGN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.15M.
The stock's 52-week range extends from a low of $1.61 to a high of $5.37.
The stock's 52-week range extends from a low of $1.61 to a high of $5.37.
People also own
Based on the portfolios of people who own ZFGN. This list is generated using Robinhood data, and it’s not a recommendation.